References
- Callaghan MU, Kaufman RJ. Cellular processing of factor VIII and factor IX. In: Lee C, Berntorp E, Hoots K, eds. Textbook of Haemophilia, 2nd edn. 2010. Oxford, UK: Wiley-Blackwell.
- Kitchen S, de Paula Cereta F, de Lima Montalvão SA, et al. Laboratory diagnosis and monitoring. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia 2020; 26(S6): 35–48. doi: 10.1111/hae.14046.
- Hatton C, Hay D, Keeling DM. Haemostasis, abnormal bleeding and anticoagulant therapy. In: Hatton C, Hay D, Keeling DM, eds. Haematology: Lecture Notes, 10th edn. 2018. Chichester, UK: Wiley-Blackwell.
- Stonebraker JS, Bolton-Maggs PHB, Brooker M, et al. The World Federation of Hemophilia Annual Global Survey 1999–2018. Haemophilia 2020; 27: 591–600. doi: 10.1111/hae.14012.
- Iorio A, Stonebraker JS, Chambost H, Makris M, Coffin D, Herr C. Establishing the male prevalence and prevalence at birth of hemophilia: A meta-analytic approach using national registries. Ann Intern Med 2019; 171(8): 540–546]. doi: 10.7326/M19-1208.
- Pipe SW, Carcao M, Chew K, et al. Hemostatic agents. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia 2020; 26(S6): 59–71. doi: 10.1111/hae.14046.
- Francini M, Mannucci M. Non-factor replacement therapy for haemophilia: a current update. Blood Transfus 2018; 16: 457–61. doi: 10.2450/2018.0272-17.
- Garrison LP, Kleinermans D. Is the world ready for gene therapy? Haemophilia 2022; 28(Supp 2): 5–8. doi: 10.1111/hae.14439.
- DeKoven M, Karkare S, Lee WC, et al. Impact of haemophilia with inhibitors on caregiver burden in the United States. Haemophilia 2014; 20: 822–830. doi: 10.1111/hae.12501.
- Khair K, Kulkowska A, Myrin Westersson L, et al. The burden of bleeds and other clinical determinants on caregivers of children with haemophilia (the BBC Study). Haemophilia 2019; 25: 416–423. doi: 10.1111/hae.13736.
- Miller CH, Bean CJ. Genetic causes of haemophilia in women and girls. Haemophilia 2021; 27: e164–e179. doi: 10.1111/hae.14186.
- Shoukat HMH, Ghulam Ghous G, Tarar ZI, Shoukat MM, Ajma N. Skewed inactivation of X chromosome: a cause of hemophilia manifestation in carrier females. Cureus 2020; 12(10):e11216. doi: 10.7759/cureus.11216.
- Kasper CK, Lin JC. How many carriers are there? Haemophilia 2010; 16(5): 842. doi: 10.1111/j.1365-2516.2010.02210.x
- van Galen K, Lavin M, Skouw-Rasmussen N, et al.; European Haemophilia Consortium (EHC), European Association for Haemophilia and Allied Disorders (EAHAD). European principles of care for women and girls with inherited bleeding disorders. Haemophilia 2021; 27(5): 837–847. doi: 10.1111/hae.14379.
- Weyand AC, James PD. Sexism in the management of bleeding disorders. Res Pract Thromb Haemost 2021; 5: 51–54. doi: 10.1002/rth2.12468.
- Khair K, Steadman L, Chaplin S, et al. Parental perspectives on gene therapy for children with haemophilia: the Exigency study. Haemophilia 2021; 27(1): 120–128. doi: 10.1111/hae.14188.
- Fletcher S, Jenner K, Holland M, Chaplin S, Khair K. An exploration of why men with severe haemophilia might not want gene therapy: the Exigency study. Haemophilia 2021; 27(5): 760–768. doi: 10.1111/hae.14378.
- Fletcher S, Jenner K, Pembroke L, Holland M, Khair K. The experiences of people with haemophilia, and their families, of gene therapy in a clinical trial setting: regaining control, the Exigency study. Orphanet J Rare Dis 2022; 17: 155. doi: 10.1186/s13023-022-02256-2.
- Stake RE. The Art of Case Study Research. 1995. London: Sage Publications.
- Schwandt TA, Gates EF. Case study methodology. In Denzin NK, Lincoln YS, eds. The SAGE Handbook of Qualitative Research, 5th edn. 2017. London: Sage Publications.
- Archibald MM, Ambagtsheer RC, Casey MG, Lawless M. Using Zoom videoconferencing for qualitative data collection: perceptions and experiences of researchers and participants. International Journal of Qualitative Methods 2019; 18: 1–8. doi: 10.1177/1609406919874596.
- S Fletcher. Seeing the bigger picture: Qualitative research in the Zoom® age. J Haem Pract 2021; 8(1): 141–144. doi: 10.2478/jhp-2021-0019.
- Alhojailan MI. Thematic analysis: A critical review of its process and evaluation. West East Journal of Social Sciences 2012; 1(1): 39–47.
- NHS Health Research Authority. Is My Study Research? October 2017. Available from
http://www.hra-decisiontools.org.uk/research/ (accessed 3 January 2022). - Denny C, Grady C. Research involving women. In: Emanuel EJ, Grady C, Crouch RA, et al., eds. The Oxford Textbook of Clinical Research Ethics. 2008. Oxford, UK: Oxford University Press.
- Steinberg JR, Turner BE, Weeks BT, et al. Analysis of female enrollment and participant sex by burden of disease in US clinical trials between 2000 and 2020. JAMA Netw Open 2021; 4(6): e2113749. doi: 10.1001/jamanetworkopen.2021.13749.
- Mastroianni AC, Faden R, Federman D. Executive summary. In Mastroianni AC, Faden R, Federman, D. Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies, vol. 1. 1994. Washington (DC): National Academies Press.
- Sterling TR, Vlahov AJ, Astemborski J, et al. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 2001; 344: 720–725. doi: 10.1056nejm2000103083441003.
- Campaigne BMN, Wishner KL. Gender-specific health care in diabetes melitus. J Gend Specif Med 2000; 3(1): 51–58. PMID: 11253237.
- Walsh SJ, Rau LM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 2000; 90: 1463–1466. doi: 10.2105/ajph90.9.1463.
- Thomas R, Page F, Khosia R, Vester A, Hana T, Say L. Ensuring an inclusive global health agenda for transgender people. Bull World Health Organ 2017; 95: 154–156. doi: 10.2471/blt.16.183913.
- Joseph A, Cliffe C, Hillyard M, Majeed A. Gender identity and the management of the transgender patient: a guide for non-specialists. J R Soc Med 2017; 110: 144–52. doi: 10.1177/0141076817696054.
- Valk C. A transgender person with haemophiia. J Haem Pract 2018; 5(1): 147–151. doi: 10.17225/jhp00128.
- Sanigorska A, Chaplin S, Holland M, Khair K, Pollard D. The lived experience of women with a bleeding disorder: A systematic review. Res Pract Thromb Haemost 2022; 6: e12652. doi: 10.1002/rth2.12652.
- van Galen KPM, d’Oiron R, James P, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. J Thromb Haemost 2021; 19: 1883–1887. doi: 10.1111/jth.15397.
- Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Res Notes 2014, 7: 264. doi: 10.1186/1756-0500-7-264.
- Carey JC. The importance of case reports in advancing scientific knowledge of rare diseases. Adv Exp Med Biol 2010; 686: 77–86. doi: 10.1007/978-90-481-9485-8_5.
- Nakamura T, Igarashi H, Ito T, Jensen RT. Important of case-reports/series, in rare diseases: Using neuroendocrine tumors as an example. World J Clin Cases 2014; 2(11): 608–613. doi: 10.12998/wjcc.v2.i11.608.
- Khair K, Pollard D, Steadman L, Jenner K, Chaplin S. The views of women with bleeding disorders: Results from the Cinderella study. Haemophilia 2022;28(2): 316–325. doi: 10.1111/hae.14514.